You may also like
Long-term support of patients receiving a left ventricular assist device for advanced heart failure: a follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System
The Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE) is an investigator-initiated multicentre, prospective, single-arm database established to collect post-Conformité Européenne Mark clinical information on patients receiving the HeartWare® Ventricular Assist System (HVAD®). The number of patients requiring longer periods of mechanical circulatory support is ever increasing and so further investigation into long-term outcomes in bridge-to-transplant populations is necessary.
1 min read
Perfusion.com Cardiovascular News Roundup: September 19, 2022
Weekly roundup of interesting reads for the perfusion community, this week including new reviews, COVID trials, transplant news, and interesting findings on blood groups.
2 min read
“New” Heparin Effect on Patient Heparin-Dose-Response and the Role of Antithrombin (EP Video)
Jeff Riley discusses the effect of the "new" heparin on the patient heparin-dose-response (27:54 minutes).
1 min read